These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 10917545)
1. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer. Jin R; Bay BH; Chow VT; Tan PH; Lin VC Br J Cancer; 2000 Aug; 83(3):319-23. PubMed ID: 10917545 [TBL] [Abstract][Full Text] [Related]
2. Stable transfection and overexpression of metallothionein isoform 3 inhibits the growth of MCF-7 and Hs578T cells but not that of T-47D or MDA-MB-231 cells. Gurel V; Sens DA; Somji S; Garrett SH; Nath J; Sens MA Breast Cancer Res Treat; 2003 Jul; 80(2):181-91. PubMed ID: 12908821 [TBL] [Abstract][Full Text] [Related]
3. Over-expression of metallothionein predicts chemoresistance in breast cancer. Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991 [TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618 [TBL] [Abstract][Full Text] [Related]
5. Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-1X mRNA in bladder cancer. Somji S; Sens MA; Lamm DL; Garrett SH; Sens DA Cancer Detect Prev; 2001; 25(1):62-75. PubMed ID: 11270423 [TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139 [TBL] [Abstract][Full Text] [Related]
7. Post-transcriptional regulation of metallothionein isoform 1 and 2 expression in the human breast and the MCF-10A cell line. Gurel V; Sens DA; Somji S; Garrett SH; Weiland T; Sens MA Toxicol Sci; 2005 Jun; 85(2):906-15. PubMed ID: 15788722 [TBL] [Abstract][Full Text] [Related]
8. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology. Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor status in female breast cancer: RT-PCR and Western blot studies. Bryś M; Wójcik M; Romanowicz-Makowska H; Krajewska WM J Cancer Res Clin Oncol; 2002 Feb; 128(2):85-90. PubMed ID: 11862478 [TBL] [Abstract][Full Text] [Related]
11. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131 [TBL] [Abstract][Full Text] [Related]
12. Expression of periostin in human breast cancer. Puglisi F; Puppin C; Pegolo E; Andreetta C; Pascoletti G; D'Aurizio F; Pandolfi M; Fasola G; Piga A; Damante G; Di Loreto C J Clin Pathol; 2008 Apr; 61(4):494-8. PubMed ID: 17938160 [TBL] [Abstract][Full Text] [Related]
13. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Abdel-Mageed A; Agrawal KC Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939 [TBL] [Abstract][Full Text] [Related]
14. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma]. Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068 [TBL] [Abstract][Full Text] [Related]
15. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
16. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Kang H; Mansel RE; Jiang WG Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737 [TBL] [Abstract][Full Text] [Related]
17. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins. Sumida T; Itahana Y; Hamakawa H; Desprez PY Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195 [TBL] [Abstract][Full Text] [Related]
18. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. Zhang R; Zhang H; Wei H; Luo X J Environ Pathol Toxicol Oncol; 2000; 19(1-2):95-7. PubMed ID: 10905514 [TBL] [Abstract][Full Text] [Related]
19. Expression of sigma 1 receptor in human breast cancer. Wang B; Rouzier R; Albarracin CT; Sahin A; Wagner P; Yang Y; Smith TL; Meric-Bernstam F; Marcelo Aldaz C; Hortobagyi GN; Pusztai L Breast Cancer Res Treat; 2004 Oct; 87(3):205-14. PubMed ID: 15528963 [TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction. Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]